N-acetylgalactosaminyltransferase 1 (GALNT1) overexpression has been reported for the aberrant glycosylation of integrin α3β1 which leads to the change in the conformation of integrin and further induces focal adhesion kinase (FAK) activation in bladder cancer cells [35]. This evidence concerns the gene GALNT1 and urinary bladder carcinoma.